Anti-CATB/ CTSB/ APPS functional antibody

Anti-CATB/ CTSB/ APPS functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to CTSB/CTSB products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-T61746-Ab-1/ GM-Tg-hg-T61746-Ab-2Anti-Human CTSB monoclonal antibodyHuman
GM-Tg-rg-T61746-Ab-1/ GM-Tg-rg-T61746-Ab-2Anti-Rat CTSB monoclonal antibodyRat
GM-Tg-mg-T61746-Ab-1/ GM-Tg-mg-T61746-Ab-2Anti-Mouse CTSB monoclonal antibodyMouse
GM-Tg-cynog-T61746-Ab-1/ GM-Tg-cynog-T61746-Ab-2Anti-Cynomolgus/ Rhesus macaque CTSB monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-T61746-Ab-1/ GM-Tg-felg-T61746-Ab-2Anti-Feline CTSB monoclonal antibodyFeline
GM-Tg-cang-T61746-Ab-1/ GM-Tg-cang-T61746-Ab-2Anti-Canine CTSB monoclonal antibodyCanine
GM-Tg-bovg-T61746-Ab-1/ GM-Tg-bovg-T61746-Ab-2Anti-Bovine CTSB monoclonal antibodyBovine
GM-Tg-equg-T61746-Ab-1/ GM-Tg-equg-T61746-Ab-2Anti-Equine CTSB monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-T61746-Ab-1/ GM-Tg-hg-T61746-Ab-2; GM-Tg-rg-T61746-Ab-1/ GM-Tg-rg-T61746-Ab-2;
GM-Tg-mg-T61746-Ab-1/ GM-Tg-mg-T61746-Ab-2; GM-Tg-cynog-T61746-Ab-1/ GM-Tg-cynog-T61746-Ab-2;
GM-Tg-felg-T61746-Ab-1/ GM-Tg-felg-T61746-Ab-2; GM-Tg-cang-T61746-Ab-1/ GM-Tg-cang-T61746-Ab-2;
GM-Tg-bovg-T61746-Ab-1/ GM-Tg-bovg-T61746-Ab-2; GM-Tg-equg-T61746-Ab-1/ GM-Tg-equg-T61746-Ab-2
Products NameAnti-CTSB monoclonal antibody
Formatmab
Target NameCTSB
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody, Therapeutics Target antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-CTSB benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-T61746-Ag-1Recombinant multi-species CATB/ CTSB/ APPS protein
    ORF Viral VectorvGMLV000311human CTSB Lentivirus particle
    ORF Viral VectorpGMLV000311human CTSB Lentivirus plasmid
    ORF Viral VectorpGMAD000496Norway rat Ctsb Adenovirus plasmid
    ORF Viral VectorpGMLPm001493mouse Ctsb Lentivirus plasmid
    ORF Viral VectorvGMAD000496Norway rat Ctsb Adenovirus particle
    ORF Viral VectorvGMLPm001493mouse Ctsb Lentivirus particle


    Target information

    Target IDGM-T61746
    Target NameCTSB
    Gene ID1508,13030,64529,100424758,486077,101084873,281105,100060963
    Gene Symbol and SynonymsAPPS,CATB,CB,CPSB,CTSB,KWE,RECEUP
    Uniprot AccessionP07858,P00787,P07688
    Uniprot Entry NameCATB_HUMAN,CATB_RAT,CATB_BOVIN
    Protein Sub-locationSecreted Protein/Potential Cytokines
    CategoryTherapeutics Target
    DiseaseMalignant neoplasm of bladder, IgA glomerulonephritis, tumors
    Gene EnsemblENSG00000164733
    Target ClassificationN/A

    The target: CTSB, gene name: CTSB, also named as APPS, CPSB, RECEUP. This gene encodes a member of the C1 family of peptidases. Alternative splicing of this gene results in multiple transcript variants. At least one of these variants encodes a preproprotein that is proteolytically processed to generate multiple protein products. These products include the cathepsin B light and heavy chains, which can dimerize to form the double chain form of the enzyme. This enzyme is a lysosomal cysteine protease with both endopeptidase and exopeptidase activity that may play a role in protein turnover. It is also known as amyloid precursor protein secretase and is involved in the proteolytic processing of amyloid precursor protein (APP). Incomplete proteolytic processing of APP has been suggested to be a causative factor in Alzheimer's disease, the most common cause of dementia. Overexpression of the encoded protein has been associated with esophageal adenocarcinoma and other tumors. Both Cathepsin B and Cathepsin L are involved in the cleavage of the spike protein from the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) upon its entry to the human host cell. Multiple pseudogenes of this gene have been identified. [provided by RefSeq, Sep 2020].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.